BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7521715)

  • 1. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
    Leng G; Finnegan MJ
    Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal morphine in the treatment of chronic intractable pain.
    Chambers FA; MacSullivan R
    Ir J Med Sci; 1994 Jul; 163(7):318-21. PubMed ID: 7528184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone and intravenous morphine requirements. Treatment of pain due to advanced cancer.
    Kepes ER; Raj S; Thomas P; Vemulapalli K
    N Y State J Med; 1983 Jun; 83(7):925-7. PubMed ID: 6193466
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
    Moryl N; Kogan M; Comfort C; Obbens E
    Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.
    Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L
    J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opioid rotation: a therapeutic choice in the management of refractory cancer pain].
    González-Barboteo J; Trelis-Navarro J; Tuca-Rodríguez A; Gómez-Batiste X
    Med Clin (Barc); 2010 Nov; 135(13):617-22. PubMed ID: 20673681
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.
    Fredheim OM; Borchgrevink PC; Klepstad P; Kaasa S; Dale O
    Eur J Pain; 2007 Aug; 11(6):599-604. PubMed ID: 17113329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonus associated with high-dose parenteral methadone.
    Ito S; Liao S
    J Palliat Med; 2008 Jul; 11(6):838-41. PubMed ID: 18715174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients.
    Karavelis A; Foroglou G; Selviaridis P; Fountzilas G
    Neurosurgery; 1996 Jul; 39(1):57-61; discussion 61-2. PubMed ID: 8805140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative dilemma: challenges of the management of a patient on mega doses of morphine and methadone.
    Kaye AD; Alian AA; Vadivelu N; Chung KS
    J Opioid Manag; 2014; 10(1):69-72. PubMed ID: 24604572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.